OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 5, Pages 2121-2126
Publisher
American Society for Microbiology
Online
2013-02-26
DOI
10.1128/aac.02413-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between β-Lactamase-EncodingblaOXA-51Variants and DiversiLab Rep-PCR-Based Typing of Acinetobacter baumannii Isolates
- (2012) Esther Zander et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Identification of the naturally occurring genes encoding carbapenem-hydrolysing oxacillinases from Acinetobacter haemolyticus, Acinetobacter johnsonii, and Acinetobacter calcoaceticus
- (2011) S. Figueiredo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Genetic basis of antibiotic resistance in pathogenic Acinetobacter species
- (2011) Laurent Poirel et al. IUBMB LIFE
- Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007
- (2011) Yvonne Pfeifer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09)
- (2011) V. Gogou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus–baumannii complex isolates from a single hospital in Korea over 7 years
- (2011) Young Kyoung Park et al. JOURNAL OF MEDICAL MICROBIOLOGY
- High Prevalence of Carbapenem-ResistantAcinetobacter baumanniiCarrying theblaOXA-143Gene in Brazilian Hospitals
- (2010) Charline S. Antonio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization and PCR-Based Replicon Typing of Resistance Plasmids in Acinetobacter baumannii
- (2010) A. Bertini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-134, a Naturally Occurring Carbapenem-Hydrolyzing Class D -Lactamase from Acinetobacter lwoffii
- (2010) S. Figueiredo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A rapid and simple method for constructing stable mutants of Acinetobacter baumannii
- (2010) Jesús Aranda et al. BMC MICROBIOLOGY
- Diversity, Epidemiology, and Genetics of Class D -Lactamases
- (2009) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-143, a Novel Carbapenem-Hydrolyzing Class D -Lactamase in Acinetobacter baumannii
- (2009) P. G. Higgins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
- (2009) Paul G. Higgins et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Global spread of carbapenem-resistant Acinetobacter baumannii
- (2009) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Functional Analysis of Insertion Sequence ISAba1, Responsible for Genomic Plasticity of Acinetobacter baumannii
- (2009) P. D. Mugnier et al. JOURNAL OF BACTERIOLOGY
- Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.
- (2008) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance
- (2008) D. W. Wareham et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Structure-function studies of arginine at position 276 in CTX-M -lactamases
- (2008) F. J. Perez-Llarena et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now